Visalytics
Visalytics
approved EB-2 (NIW)

Graduate Student Researcher

Pharmaceutical Chemistry · China · 2025-01-08

Processing Time
426 days
Decision Date
2025-01-08
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research in pharmaceutical chemistry with a focus on drug discovery optimization and the development of advanced computational techniques. This work involves identifying new therapeutics for human diseases and creating computational methods that offer significant advantages over conventional drug discovery approaches. The intended impact is to reduce the economic and social costs of disease while improving global public health.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research in drug discovery optimization is relevant to identifying new therapeutics and reducing the economic costs of disease.

2 Well-positioned to Advance the Endeavor Met

The petitioner's work has been cited 362 times, indicating that other researchers consistently look to his methods to guide their studies.

3 Waiver of Job Offer and Labor Certification Met

The petitioner's contributions to computational techniques for drug discovery make him an invaluable asset to U.S. health and prosperity.

Why This Petition Was Approved

The petition was approved based on the petitioner's 362 citations and a publication record including 3 peer-reviewed journal articles and 1 conference article. Evidence showed the work was supported by major federal funding from the National Institutes of Health (NIH) and the National Science Foundation (NSF). The case successfully satisfied all three Dhanasar prongs by demonstrating the national importance of drug discovery and the petitioner's well-positioned status in the field.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Conference Presentations
Original Contributions
Government Alignment

Similar Cases

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
Wisconsin 94 days 2025-01-29
The petitioner proposes to investigate the design, synthesis, optimization, and characterization of small molecule compounds. This work focuses on developing therapeutic agents to address drug-resistant infections and improve medication safety and efficacy.
View Case

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.
View Case

Research Scientist

Research and Development · Taiwan

WeGreened EB-2 (NIW) approved
Indiana 552 days 2025-04-26
The petitioner proposes to develop advanced bioanalytical chemistry techniques to improve molecular characterization and expedite the drug discovery process. His work focuses on investigating biological processes driving neurodegenerative disorders, metabolic diseases, and cancer to facilitate new therapies. Additionally, he aims to enhance quality control measures within pharmaceutical manufacturing.
View Case

Scientist

Pharmaceuticals · Bangladesh

WeGreened EB-2 (NIW) approved
Massachusetts 69 days 2022-04-19
The petitioner proposes to continue analyzing synthetic routes to isolate, synthesize, design, and ensure the safety of novel drug molecules. This work is part of innovative drug discovery projects aimed at treating cancer, heart disease, and infectious diseases to improve global and U.S. healthcare outcomes.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-08.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 426 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist